Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial
about
Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial
description
scientific article published on 24 October 2019
@en
name
Avelumab monotherapy as first- ...... the JAVELIN Solid Tumor trial
@en
type
label
Avelumab monotherapy as first- ...... the JAVELIN Solid Tumor trial
@en
prefLabel
Avelumab monotherapy as first- ...... the JAVELIN Solid Tumor trial
@en
P2093
P1476
Avelumab monotherapy as first- ...... the JAVELIN Solid Tumor trial
@en
P2093
Alain Ravaud
Christian Borel
Dongli Zhou
James L Gulley
John C Morris
Jorge Chaves
Julio Peguero
Marcis Bajars
Martin Smakal
Nuria Kotecki
P356
10.1186/S40425-019-0746-2
P577
2019-10-24T00:00:00Z